| Literature DB >> 26015292 |
Rhoda Allison1, Laura Shenton1, Kathryn Bamforth1, Cherry Kilbride2, David Richards3.
Abstract
BACKGROUND ANDEntities:
Keywords: disability; pain; spasticity; stroke
Mesh:
Year: 2015 PMID: 26015292 PMCID: PMC5157782 DOI: 10.1002/pri.1634
Source DB: PubMed Journal: Physiother Res Int ISSN: 1358-2267
Figure 1Search results
Outcomes and predictor measures used in the studies
| Outcome measures | Predictors of impairment which were assessed | |||
|---|---|---|---|---|
| Pain | ||||
|
De Jong et al., | MAS (elbow flexors) | Motor control (FMMA) | ||
|
Kong et al., | AS (shoulder, elbow, wrist and fingers) | Stroke severity (NIHSS) | Global function (mod BI) | Weakness (UEMI) |
| Sensation (MAND) | ||||
|
Kong et al., | AS (shoulder, elbow, wrist and fingers) | NA | ||
| Kuptniratsaikul | MAS (elbow and knee) | NA | ||
|
Leathley et al., | Tone assessment scale | Higher cortical dysfunction | Global function (BI) | Weakness (3‐point scale) |
|
Watkins et al., | MAS (wrist, elbow) | (aphasia, confusion or inattention) | Side of stroke | Gender |
| Premorbid function (mRS) | Diabetes | |||
| Lundstrom et al., | MAS (shoulder, elbow, wrist, fingers, hip, knee and ankle) | Stroke severity (NIHSS) | Weakness (ssNIHSS) | Sensation (ssNIHSS) |
| Global function (mRS) | ||||
|
Lundstrom et al., | MAS (all arm and leg joints) | NA | ||
|
Moura et al. | MAS (unclear which joint assessed) | Weakness (MST) | Gender | Age |
| Pain (any report) | ||||
|
Pandyan et al., | MAS (wrist) | Arm function (ARAT) | ||
|
Picelli et al., | MAS (shoulder, elbow, wrist and fingers) | Motor control (items of European Stroke Scale) | ||
|
Sommerfeld et al., | MAS (all arm and leg joints) | NA | ||
|
Urban et al., | MAS (all arm and leg joints) | Sensation (LT‐MAND) | Weakness (BMRC) | |
|
Van Kujik et al., | AS (elbow and wrist) | Arm control (FMMA) | Global function (BI) | Sensation (LT & FTT) |
| Apraxia (clinical observation) | Inattention (MAND) | |||
| Pain | ||||
|
Appelros, | Pain‐open question at assessment | Stroke severity (NIHSS) | Sensation (ss NIHSS) | Motor function (ss NIHSS) |
|
Lundstrom et al., | Pain‐VAS | None | ||
|
Sommerfeld and Welmer, | Pain‐interview | Sensation light touch (perceiving touch with cotton wool) | Motor control (BL) | Global function (BI) |
| Spasticity (MAS) | Proprioception (FTT) | |||
|
Aras et al., | Pain‐MAND | NA | ||
|
Bohannon | Pain‐reported during examination | NA | ||
|
Cheng et al., | Pain‐MAND | NA | ||
|
Gamble et al. | Pain‐VAS | Mood (HADS) | Sensation (LT) | Global function (BI) |
|
Gamble et al., | ||||
| Weakness (ssNIHSS) | ||||
|
Hadianfard and Hadianfard, | Pain‐VAS | Global function (Kenny) | Aphasia (any problem with | Visual field (MAND) |
| Motivation (MAND) | speech) | Mood (symptom checklist) | ||
| Sensation (NSAS and LT) | ||||
| Kuptniratsaikul | Pain‐MAND | NA | ||
|
Lindgren et al., | Pain‐VAS | Side of hemiplegia | Stroke severity (NIHSS) | |
|
Lindgren et al., | Pain‐VAS | Side of hemiplegia | Stroke severity (NIHSS) | |
|
O'Donnell et al., | Pain‐self report; | Stroke severity (NIHSS) | Gender | Depression (‘feeling sad’) |
| Neurologist assessed the cause (MAND) | Alcohol intake (no. of drinks) | Smoker | Previous exercise | |
| Global function (mRS) | ||||
|
Paci et al., | Pain‐dichotomous response to pain at rest/ on mvt | Shoulder subluxation (palpation) | Motor control (FMMA) | Pain |
|
Pong et al., | Pain‐VAS | Motor control (BMR) | ROM (goniometer) | Sensation (MAND) |
| Spasticity (AS) | ||||
|
Poulin de Courval et al., | Pain‐ reported during physical examination | NA | ||
|
Rajaratnam et al., | Pain‐ numerical rating scale | NA | ||
|
Ratnasabapathy et al., | Pain‐ questionnaire designed by study team | NA | ||
|
Roosink et al., | Pain‐numerical rating scale at rest & on movement | NA | ||
|
Sackley et al., | Pain‐ reported during physical examination | NA | ||
|
Suethanapornkul and Kuptniratsaikul, | Pain‐ MAND | Global function (BI) | Subluxation (MAND) | Mood (HADS) |
| Spasticity (MAS) | Motor control (Brunnstrom) | Cognition (Thai mental state exam) | ||
| Proprioception (MAND) | ||||
|
Wanklyn et al., | Pain‐ questionnaire designed by study team | NA | ||
|
Zorowitz et al., | Pain‐ VAS | NA | ||
| Contracture | ||||
|
Sackley et al. | 30% reduction in ROM (MAND) | NA | ||
|
Ada et al. | ROM at elbow (measured from photograph‐ MAND) | NA | ||
|
Kwah et al., | Torque‐controlled ROM at elbow wrist and ankle | Spasticity (Tardieu) | Stroke severity (NIHSS) | Motor control (Mot Ass Scale) |
| All other joints‐ 4 point scale of movement restriction | Pain (NRS) | Strength (Manual muscle test) | ||
|
Malhotra et al., | ROM at wrist with standardized force | Arm function (ARAT) | ||
|
Pandyan et al., | ROM wrist (goniometry with standard force) | Weakness (grip dynamometer) | ||
MAND = method of assessment not described; ARAT = action research arm test; AS = Ashworth scale; BMRC = British medical research council; BI = Barthel Index; BL = Birgitte Lindmark Motor Assessment; BMR = Brunnstrom motor recovery; FMMA = Fugl–Meyer motor assessment; FTT = Find the thumb; HADS = Hospital anxiety and depression scale; LT = light touch; MAS = Modified Ashworth Scale; Mod BI = Modified Barthel Index; MMSE = mini mental state exam; Mot Ass Scale = Motor assessment scale; mRS = Modified Rankin Score; MST = muscle strength test; NSAS = Nottingham Sensory Assessment Scale; NIHSS = National Institutes for Health Stroke Scale; ROM = range of movement; ssNIHSS = sub‐scale of NIHSS; UEMI = Upper extremity motor index; VAS = visual analogue scale.
Characteristics of participants and studies
| Setting | Sample size | Targeted population | Time since stroke at recruitment (days) | Average age at recruitment (years) | Impairment studied | Design | |
|---|---|---|---|---|---|---|---|
|
Appelros, | Sweden | 253 | People with first‐ever stroke | Fixed: onset | 74 (33–95) | Pain‐general | Longitudinal |
|
Ada et al., | Australia | 18 | People with stroke, with hemiplegia | Variable: 17 (14–28) | 63 (36–82) | Contracture‐elbow | Longitudinal |
|
Aras et al., | Turkey | 85 | People with hemiplegia and receiving rehabilitation | Variable: not stated | 59.5 (47–70) | Pain‐shoulder | Cross‐sectional |
|
Bohannon, | United States | 30 | People with stroke, with hemiplegia and receiving rehabilitation | Variable: 31 (SD 15) | 68 (SD 10.6) | Pain‐shoulder | Longitudinal |
|
Cheng et al., | Taiwan | 50 | People with stroke, receiving inpatient rehabilitation | Variable: 21–180 | 62 (40–79) | Pain‐shoulder | Cross‐sectional |
|
De Jong et al., | The Netherlands | 50 | People with first ischaemic stroke with arm weakness, receiving TMS | Variable: within 48 hours | 70.3 (58–82) | Spasticity‐elbow | Longitudinal |
|
Gamble et al. | UK | 123 | People with stroke | Fixed: 14 | 70.6 (29–93) | Pain‐shoulder | Longitudinal |
|
Gamble et al., | |||||||
|
Hadianfard and Hadianfard, | Iran | 152 | People with stroke | Variable: 0–60 | 61 (40–75) | Pain‐shoulder | Longitudinal |
|
Kong et al., | Singapore | 148 | People with stroke, with weakness and receiving rehabilitation | Variable: not reported | 63 (53–76) | Spasticity‐arm | Longitudinal |
|
Kong et al., | Singapore | 140 | People with stroke, with weakness and receiving rehabilitation | Variable: 15 (SD 14.6) | 61 (SD 13.3) | Spasticity‐arm | Longitudinal |
|
van Kujik et al., | Holland | 40 | People with ischaemic stroke, with complete arm paralysis | Fixed: onset | 68 (59–77) | Spasticity‐arm | Longitudinal |
| Kuptniratsaikul | Thailand | 214 | People with stroke | Variable: (median 24) | 62 (59–75) | Spasticity‐general | Longitudinal |
|
Kwah et al., | Australia | 165 | People with stroke | Variable: up to 28 days | 78 (IQR 65–84) | Contracture‐general | Longitudinal |
|
Leathley et al., | UK | 106 | People with stroke | Fixed: onset | 70 (SD 11.3) | Spasticity‐general | Longitudinal |
|
Watkins et al., | |||||||
|
Lindgren et al., | Sweden | 327 | People with first ever stroke | Fixed: onset | 73 (17–102) | Pain‐shoulder | Longitudinal |
|
Lindgren et al., | 58 (subset) | People with first ever stroke, with motor or sensory deficit and pain | 71 | ||||
|
Lundstrom et al., | Sweden | 47 | People with first ever stroke and initial weakness | Variable: 2–10 days | 74 (34–84) | Spasticity‐arm or leg | Longitudinal |
|
Lundstrom et al., | Sweden | 140 | People with first stroke | Fixed: 12 months | 71 (SD 13) | Pain‐general | Cross |
|
Lundstrom et al., | Spasticity‐arm | sectional | |||||
|
Malhotra et al., | UK | 30 | People with first stroke and no function of arm | Variable: 21 (range 7–35) | 70 (52–90) | Contracture‐wrist | Longitudinal |
|
Moura et al. | Brazil | 146 | People with ischaemic stroke | Fixed: onset | 64 (25–88) | Spasticity‐general | Longitudinal |
|
O'Donnell et al., | 35 countries | 15754 | People with non‐severe ischaemic stroke, over 50 years | Variable: (median 15) | 65 (not reported) | Pain‐general | Longitudinal |
|
Paci et al., | Italy | 107 | People with first stroke and hemiplegia receiving rehabilitation | Variable: 7–27 days | 72 (62–82) | Pain‐shoulder | Longitudinal |
|
Pandyan et al., | UK | 22 | People with stroke, with weakness | Variable: 14–28 | 65 (40–93) | Contracture‐wrist | Longitudinal |
| Spasticity‐ wrist | |||||||
| Picelli et al., | Italy | 72 | People with first ischaemic stroke, with hemiplegia and receiving rehabilitation but not receiving medications for spasticity | Variable: within 7 days | 71 (SD 10) | Spasticity‐arm | Longitudinal |
|
Pong et al., | Taiwan | 76 | People with first stroke, with hemiplegia | Variable: not reported | 59 (SD 13) | Pain‐shoulder | Longitudinal |
|
Poulin de Courval et al., | Canada | 94 | People with stroke, with hemiplegia and receiving rehabilitation | Variable: 21–35 | Not reported | Pain‐shoulder | Cross‐sectional |
|
Rajaratnam et al., | Singapore | 135 | People with unilateral stroke | Variable: 2–14 | 64 (SD 10.8) | Pain‐shoulder | Cross sectional |
|
Ratnasabapathy et al., | New Zealand | 1201 | People with first ever stroke | Variable: 0–14 | Not reported | Pain‐shoulder | Longitudinal |
|
Roosink et al., | The Netherlands | 31 | People with first ever stroke, with sensory or motor signs | Fixed: 2 weeks | 67 (52–82) | Pain‐shoulder | Longitudinal |
|
Sackley et al. | UK | 73 | People with Barthel score of <10 at 3 months post‐stroke | Fixed: 3 months | 76 (31–98) | Pain‐shoulder | Longitudinal |
| Contracture‐general | |||||||
| Sommerfeld et al., | Sweden | 95 | People with first ever stroke | Fixed: onset | 78 (SD 9.5) | Pain‐general | Longitudinal |
| 66 (subset) | Spasticity‐general | ||||||
|
Suethanapornkul and Kuptniratsaikul, | Thailand | 327 | People with stroke who could sit out of bed for 30 minutes | Variable: 84 | 62 (50–74) | Pain‐shoulder | Longitudinal |
|
Urban et al., | Germany | 211 | People with first stroke, with weakness | Variable: not reported | 68 (59–78) | Spasticity‐general | Longitudinal |
| Spasticity‐arm | |||||||
|
Wanklyn et al., | UK | 108 | People with stroke, with ongoing disability returning home | Variable: not reported | Not reported | Pain‐ shoulder | Longitudinal |
|
Zorowitz et al. | United States | 20 | People with stroke presenting with shoulder subluxation | Variable: 13–40 | 63 (42–83) | Pain‐shoulder | Cross sectional |
SD = Standard deviation; TMD = Transcranial magnetic stimulation.
Potential risk of bias in included studies (positive response indicates less risk of bias)
| Is sample representative of target population? | Are assessors blinded? | Are data collection tools reliable and valid? | Are withdrawals reported? | Were participants unlikely to receive an unintended intervention? | Was statistical analysis appropriate? | |
|---|---|---|---|---|---|---|
|
Appelros, | Yes | No | No | Yes | Yes | Yes |
|
Ada et al., | Yes | No | No | No | Yes | Yes |
|
Aras et al., | No | No | No | Yes | No | Yes |
|
Bohannon | Yes | No | No | Yes | Yes | Yes |
|
Cheng et al., | No | No | No | Yes | Yes | Yes |
|
De Jong et al., | No | No | Yes | Yes | Yes | Yes |
|
Gamble et al. | Yes | No | No | Yes | Yes | Yes |
|
Gamble et al., | Yes | No | No | Yes | Yes | Yes |
|
Hadianfard and Hadianfard, | Yes | No | No | Yes | Yes | No |
|
Kong et al., | No | No | Yes | Yes | No | Yes |
|
Kong et al., | Yes | No | No | Yes | No | Yes |
|
van Kujik et al., | No | No | Yes | Yes | No | Yes |
| Kuptniratsaikul | No | No | No | No | Yes | Yes |
|
Kwah et al., | Yes | No | Yes | Yes | Yes | Yes |
|
Leathley et al., | Yes | No | Yes | Yes | Yes | Yes |
|
Lindgren et al., | Yes | No | No | Yes | Yes | Yes |
|
Lindgren et al., | Yes | No | No | Yes | Yes | Yes |
|
Lundstrom et al., | Yes | No | Yes | Yes | Yes | Yes |
|
Lundstrom et al., | Yes | No | No | Yes | Yes | Yes |
|
Lundstrom et al., | Yes | No | Yes | Yes | No | Yes |
|
Malhotra et al., | Yes | No | Yes | Yes | Yes | Yes |
|
Moura et al. | No | No | No | Yes | No | Yes |
|
O'Donnell et al., | No | No | No | Yes | Yes | Yes |
|
Paci et al., | Yes | No | Yes | Yes | No | Yes |
|
Pandyan et al., | No | No | Yes | Yes | Yes | Yes |
|
Picelli et al., | No | No | Yes | No | Yes | Yes |
|
Pong et al., | No | No | No | Yes | Yes | Yes |
|
Poulin de Courval et al., | Yes | Yes | No | Yes | No | Yes |
|
Rajaratnam et al., | No | No | No | Yes | Yes | Yes |
|
Ratnasabapathy et al., | Yes | No | No | Yes | Yes | Yes |
|
Roosink et al., | Yes | No | No | Yes | Yes | No |
|
Sackley et al. | Yes | No | No | No | Yes | Yes |
|
Sommerfeld and Welmer, | Yes | No | Yes | No | Yes | Yes |
|
Sommerfeld et al., | Yes | No | Yes | Yes | No | Yes |
|
Suethanapornkul et al., | Yes | No | No | No | No | Yes |
|
Urban et al., | Yes | No | Yes | Yes | Yes | Yes |
|
Wanklyn et al., | Yes | No | No | Yes | Yes | Yes |
|
Watkins et al., | Yes | No | Yes | Yes | Yes | Yes |
|
Zorowitz et al. | No | No | No | Yes | No | Yes |
Studies of spasticity: individual results
| Study | Incidence of impairment | Reporting of change over time | Value of predictors |
|---|---|---|---|
| Studies which recruited a general population of people post stroke | |||
| Kuptniratsaikul | 18% at 12 months | Not examined | Not examined |
|
Leathley et al., | 36% at 12 months | Not examined | 1. Any degree of spasticity predicted by |
| ↓ global function ( | |||
| weakness ( | |||
| 2. Severe spasticity predicted by: | |||
| ↓ global function ( | |||
| Right sided stroke ( | |||
|
Watkins et al., | Severe spasticity in 20% at 12 months | 3. No relationship with higher cortical dysfunction, gender, diabetes and pre‐morbid function | |
|
Lundstrom et al., | 4% at up to 10 days, 27% at 1 month; 23% at 6 months | Not examined | 1. Spasticity predicted by |
| weakness (OR = 10: 95% CI: 2.1–48.4) | |||
| stroke severity ( | |||
| 2. No relationship with sensation or global disability | |||
|
Lundstrom et al., | 17% at 1 year | Not examined | Not examined |
| 6% had ‘disabling’ spasticity in the arm | |||
|
Moura et al., | 26% at final timepoint | Not examined | 1. Spasticity predicted by |
| pain ( | |||
| weakness ( | |||
| 2. No relationship with gender or age | |||
|
Sommerfeld et al., | 20% at 1 week, 18% at 3 months | Prevalence decreased over time | Not examined |
| Studies which recruited a population of people post stroke with hemiplegia or weakness | |||
|
De Jong et al., | 10% at 48 hours, 20% at 10 days, 42% at 3 months and 42% at 6 months | Some cases resolved at each time point with 1 new case at 6 months | Spasticity predicted by |
| ↓ motor control ( | |||
|
Kong et al., | 33% at 3 months, 43% at 6 months and 47% at 1 year | Some cases resolved at 12 months, with some new cases at 6 and 12 months | 1. Moderate to severe spasticity predicted by: |
| ↓ global function ( | |||
| Severe spasticity in 17% | ↓ motor control ( | ||
| stroke severity ( | |||
| 2. No relationship with sensation | |||
|
Kong et al., | 78%, severe in 38% | Not examined | Not examined |
|
van Kujik et al., | 63% at any time point | Spasticity evident in 1 week, some cases resolved over all timepoints and few new cases at 26 weeks | No relationship between spasticity and arm control, global function, sensation, apraxia or Inattention |
| 55% at 26 weeks | |||
|
Pandyan et al., | Not reported | Spasticity evident in 1 week, and developed over 32 weeks | Spasticity predicted by |
| ↓arm function ( | |||
|
Picelli et al., | 44% had severe spasticity at 6 months | Not examined | Spasticity predicted by: |
| ↓ motor control (OR = 0.45 95% CI 0.31–0.65) | |||
|
Urban et al., | 43% | Not examined | Spasticity predicted by |
| weakness ( | |||
| 16% had severe spasticity | |||
| ↓sensation ( | |||
Studies of pain: individual results
| Study | Incidence of impairment | Reporting of change over time | Value of predictors |
|---|---|---|---|
| Studies which recruited a general population of people post stroke | |||
|
Appelros, | 11% reported any pain at 1 year | Not examined | Pain predicted by: |
| stroke severity (OR = 1.24 95% CI: 1.11–1.39) | |||
| weakness (OR 1.8 95% CI: 1.3–2.7) | |||
| ↓sensation (OR 3.2 95% CI: 1.5–6.5) | |||
|
Gamble et al. | 25% developed shoulder pain at 2 weeks; 40% developed shoulder pain within 6 months | 80% of cases had resolved at 6 months | Shoulder pain predicted by |
| ↓sensation ( | |||
| weakness ( | |||
| No relationship with depression or global function | |||
|
Hadianfard et al., | 32% reported shoulder pain within first year | 6% reported shoulder pain in first 2 months, 12% within 4 months and 11% within 6 months | Shoulder pain predicted by |
| Occasional case reported after 6 months | ↓sensation ( | ||
| aphasia ( | |||
| ↓ global function ( | |||
| depression ( | |||
| ↓motivation ( | |||
| No relationship with visual field deficit | |||
| Kuptniratsaikul | 34% reported shoulder pain at 12 months | Not examined | Not examined |
|
Lindgren et al., | 22% reported shoulder pain within 4 months; 72% of these still had pain at 16 months | Few new cases at 16 months but resolved cases at all timepoints | Shoulder pain predicted by |
|
Lindgren et al., | stroke severity ( | ||
| left hemiplegia ( | |||
|
Lundstrom et al., | 21% report stroke pain at 1 year | Not examined | Not examined |
|
O'Donnell et al., | 10.6% report chronic pain | Not examined | Chronic pain predicted by: |
| Stroke severity (OR = 1.07 95% CI: 1.05–1.09) | |||
| Previous depression (OR = 1.67 95% CI: 1.47–1.89) | |||
| Previous alcohol intake (OR = 1.37 95% CI: 1.11–1.7) | |||
| Diabetes mellitus (OR = 1.18 95% CI: 1.05–1.33) | |||
| Peripheral vascular disease (OR = 1.44 95% CI: 1.09–1.91) | |||
| Female sex | |||
| Statin use | |||
|
Rajaratnam et al., | 22% reported shoulder pain within 1 week | Not examined | Not examined |
|
Ratnasabapathy et al., | 17% at 1 week, 20% at 1 month, 23% reported shoulder pain at 6 months | Pain presented within 1 week, 72% of cases had resolved at 6 months | Not examined |
|
Sommerfeld et al., | 17% initially, 21% at 3 months, 17% at 18 months | Pain predicted by | |
| ↓sensation ( | |||
| ↓mobility ( | |||
| No relationship with spasticity, motor control or global function | |||
|
Suethanapornkul and Kuptniratsaikul, | 19% developed shoulder pain | Pain resolved in 77% of cases | Pain predicted by: |
| Shoulder subluxation (OR 2.06 95% CI: 1.08–3.95) | |||
| No relationship with motor control, spasticity, proprioception, cognition, global function or mood | |||
Studies of contracture: individual results
| Study | Areas of bias quality score (lower score = increased risk of bias) | Incidence of impairment | Reporting change over time | Value of predictors |
|---|---|---|---|---|
| Studies which recruited a population of people post stroke with hemiplegia or severe stroke | ||||
|
Ada et al., | 3/6 | 51% of those with hemiplegia developed contracture | Contracture evident by 2 weeks and plateaued by 9 weeks | Not examined |
|
Kwah et al., | 5/6 | 52% develop contracture | Not examined | Contracture predicted by |
| stroke severity ( | ||||
| weakness ( | ||||
| ↓motor function ( | ||||
| No relationship with pain or spasticity | ||||
|
Malhotra et al., | 5/6 | 100% of those without function develop contracture | Contracture evident by 6 weeks and plateaued by 24 weeks | Contracture predicted by: |
| ↓function ( | ||||
|
Pandyan et al., | 4/6 | Not reported | Contracture evident by 6–8 weeks and developed over 32 weeks | Contracture predicted by |
| Weakness ( | ||||
|
Sackley et al., | 3/6 | 43% had contracture at 3 months, 56% at 6 months and 67% at 12 months | Not examined | Not examined |